TrialPloS one2015

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.

Carmen Elena Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.